Khaitan, Trilegal, S&R guide Glenmark Pharma’s $680 mln sale of GLS stake to Nirma
BY Nimitt Dixit |
Indian law firm S&R Associates has advised Glenmark Pharmaceuticals on the proposed divestment of 75 percent stake in Glenmark Life Sciences (GLS) for $680 million to Nirma, which was represented by Khaitan & Co.